OR WAIT null SECS
September 02, 2020
A new approach to testing water content in biologics is needed that will give a more accurate determination of actual water content in the biologic.
August 31, 2020
How real estate can accelerate productivity as life sciences companies prioritize COVID-19 therapeutics, vaccines, and new diagnostics R&D amidst new guidelines.
August 28, 2020
The register supports cross-functional teams of chemists and biologists in developing non-natural, chemically-modified therapeutics for drug discovery.
AbCellera’s recent acquisition of the OrthoMab bispecific platform is expected to accelerate antibody product development.
In the study, GigaGen presents a novel technology for producing a new class of drug, recombinant hyperimmunes, that may potentially generate new COVID-19 therapies.
Thermo Fisher Scientific is increasing access to cry-electron microscopy with the help of contract research organizations.
August 07, 2020
The award will help a bioanalytics startup commercialize instrument technology for pharmaceutical antibody manufacturers.
August 05, 2020
The use of analytical assays is crucial for determining that biosimilar critical quality attributes remain on point.
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.
The company’s SLIM technology has been a part of the company’s accelerated growth by offering enhanced R&D analytics.